Verition Fund Management’s Checkpoint Therapeutics CKPT Stock Holding History

Verition Fund Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-150,000	Closed	-$606K	–	3659
2025 Q1	$606K	Buy	+150,000	New	+$500K	﹤0.01%	2459

Verition Fund Management's CKPT Position: Q2 2025 in Review

Verition Fund Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 150,000 shares — an estimated $606K sold.

Verition Fund Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $606K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Verition Fund Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Verition Fund Management sold 150,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $606K.
Verition Fund Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Verition Fund Management's Checkpoint Therapeutics position peaked at $606K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.